• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Hospira

Hospira

Hospira Inc HSP 3 Star

Last Price$89.40Day Change (%)-0.02%
Open Price$89.37Day Change ($)-0.02
Day Range89.32–89.4652-Week Range46.56–89.46

As of Thu 7/30/2015 5:47:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Pfizer Boosts Its Earnings Outlook -- Update

    Pfizer Boosts Its Earnings Outlook -- Update

  2. Pfizer Boosts Its Earnings Outlook

    Pfizer Boosts Its Earnings Outlook

  3. Research and Markets: Biosimilars Market by Product (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin) - Global Forecasts to 2020

    Research and Markets: Biosimilars Market by Product (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin) - Global Forecasts to 2020

  4. Mid-Value Funds All Over the Map

    Most of Morningstar's top Medalists are shining in a pack of broad returns.

  5. Research and Markets: Haemophilus Influenzae Infections - API Insights 2015-2016

    Research and Markets: Haemophilus Influenzae Infections - API Insights 2015-2016

  6. Pfizer's Acquisition of Hospira Strengthens Its Moat at a Fair Price

    Despite the high 39% premium to Hospira's stock price, we believe the acquisition price is justified based on Pfizer's ability to unlock more value with its global reach.

  7. Hospira HSP Q1 2014 Earnings Call Transcript

    Welcome to Hospira's First Quarter 2014 Conference Call. All lines have been placed on listen-only mode to prevent any background noise. Following the speakers' remarks, there will be a question-and-answer period.

  8. Health Care: A Few Stocks Still Offer Upside

    Despite the sector looking slightly overvalued, we still see stocks with attractive valuations across the different industries.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.